ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,967 | +2242.5% | 234,619 | +877.6% | 0.00% | – |
| Q4 2022 | $12,720 | -33.1% | 24,000 | -9.4% | 0.00% | – |
| Q3 2022 | $19,000 | -53.7% | 26,500 | -26.9% | 0.00% | – |
| Q2 2022 | $41,000 | -89.5% | 36,267 | -81.0% | 0.00% | – |
| Q1 2022 | $390,000 | -86.8% | 190,446 | -81.4% | 0.00% | – |
| Q4 2021 | $2,950,000 | +52.5% | 1,024,322 | +124.6% | 0.00% | – |
| Q3 2021 | $1,934,000 | -36.3% | 456,065 | -20.6% | 0.00% | – |
| Q2 2021 | $3,037,000 | -34.5% | 574,200 | -42.4% | 0.00% | – |
| Q1 2021 | $4,634,000 | +34.0% | 996,680 | -4.9% | 0.00% | – |
| Q4 2020 | $3,458,000 | +127.1% | 1,048,250 | +127.8% | 0.00% | – |
| Q3 2020 | $1,523,000 | -21.9% | 460,256 | -20.5% | 0.00% | – |
| Q2 2020 | $1,951,000 | -31.8% | 578,921 | -22.4% | 0.00% | – |
| Q1 2020 | $2,860,000 | -47.4% | 746,480 | -17.1% | 0.00% | -100.0% |
| Q4 2019 | $5,441,000 | +7.2% | 900,693 | +34.1% | 0.00% | -50.0% |
| Q3 2019 | $5,076,000 | -90.4% | 671,417 | -82.7% | 0.00% | -71.4% |
| Q2 2019 | $52,741,000 | +2494.2% | 3,892,164 | +937.4% | 0.01% | – |
| Q1 2019 | $2,033,000 | +71.7% | 375,197 | -6.0% | 0.00% | – |
| Q4 2018 | $1,184,000 | -78.1% | 398,994 | -39.8% | 0.00% | -100.0% |
| Q3 2018 | $5,406,000 | +73.4% | 662,562 | +107.0% | 0.00% | +100.0% |
| Q2 2018 | $3,118,000 | +158.3% | 320,091 | +130.4% | 0.00% | – |
| Q1 2018 | $1,207,000 | -74.3% | 138,900 | -63.0% | 0.00% | -100.0% |
| Q4 2017 | $4,703,000 | -19.9% | 375,633 | -46.5% | 0.00% | -33.3% |
| Q3 2017 | $5,874,000 | -56.3% | 702,600 | -11.4% | 0.00% | -50.0% |
| Q2 2017 | $13,457,000 | +284.3% | 793,000 | +355.2% | 0.01% | +500.0% |
| Q1 2017 | $3,502,000 | +271.4% | 174,200 | +187.9% | 0.00% | – |
| Q4 2016 | $943,000 | – | 60,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |